6/22/2020 7:13:18 AM
Invitae To Combine With ArcherDX To Create A Genetics Leader In Cancer Genetics And Precision Oncology
4/7/2020 7:35:57 AM
Invitae Announces Enhanced Capabilities To Support Telemedicine
4/1/2020 11:27:01 PM
Invitae Prices Public Offering Of 17.78 Mln Shares At $9.00/shr
4/1/2020 4:18:58 PM
Invitae Announces Proposed Public Offering Of Common Stock
3/23/2020 7:33:37 AM
Invitae And MDA Expand Access To No-Charge Genetic Testing In U.S. And Canada
11/15/2019 8:15:58 AM
Invitae Launches Invitae Discover Research Platform On Apple Watch
9/6/2019 7:01:53 AM
Invitae Prices $300.0 Mln Of 2.00% Convertible Senior Notes Due 2024 (
9/4/2019 4:27:05 PM
Invitae Announces Proposed Offering Of $200 Mln Of Convertible Senior Notes
6/17/2019 7:35:26 AM
Invitae To Buy Singular Bio; Acquisition To Close In The Coming Weeks; Transaction Will Be Cash Neutral At Close
6/12/2019 7:33:18 AM
Invitae Announces Launch Of ID YOUR IRD Initiative
3/6/2019 9:35:38 PM
Invitae Announces Exercise In Full Of Underwriters' Option To Purchase Additional Shares Of Common Stock